UBS, Surpasses

UBS Surpasses Key Financial Targets Ahead of Schedule

17.03.2026 - 03:56:40 | boerse-global.de

UBS outlines AGM agenda with $1.10 dividend, new board nominees, and faster-than-expected Credit Suisse integration savings, despite share price decline.

UBS Surpasses Key Financial Targets Ahead of Schedule - Bild: über boerse-global.de
UBS Surpasses Key Financial Targets Ahead of Schedule - Bild: über boerse-global.de

UBS has outlined its agenda for the upcoming Annual General Meeting, presenting shareholders with a combination of robust shareholder returns and high-profile board nominations. This comes as the bank’s shares, which closed at €32.54 on Monday, have declined approximately 19% since the start of the year. Operationally, however, management is signaling clear strength, highlighted by a cash dividend of $1.10 and unexpectedly rapid progress in integrating Credit Suisse.

Operational Momentum and Elevated Savings Goals

The current business report provides concrete data on the Credit Suisse acquisition, revealing the integration is proceeding faster than initially planned. By the end of 2025, UBS had already migrated 85% of Swiss client accounts onto its own platforms. The cost savings story is even more compelling: the bank has achieved cumulative gross savings of $10.7 billion, surpassing its $10 billion target ahead of schedule. Management has now identified further potential, raising the total cost-reduction goal for the end of 2026 to $13.5 billion.

The fiscal year just concluded saw UBS report a net profit of nearly $7.8 billion. Alongside the planned profit participation for shareholders, the bank is optimizing its capital structure. Shares repurchased under the 2024 buyback program are set to be cancelled.

Strategic Appointments to the Board

The proposed refresh of the bank’s supervisory board is particularly noteworthy. UBS has nominated two international heavyweights: Luca Maestri, Chief Financial Officer of Apple, and Agustín Carstens, General Manager of the Bank for International Settlements (BIS). These candidates underscore the bank’s ambition to embed top-tier expertise in both technological innovation and global monetary policy at the highest level of governance.

Should investors sell immediately? Or is it worth buying UBS?

Navigating the Future Regulatory Landscape

This operational momentum will soon intersect with pivotal political decisions. The Swiss government is scheduled to decide on additional capital requirements for systemically important banks in April 2026. Key agenda items include the valuation of intangible assets and the capital backing for foreign subsidiaries. Until then, UBS’s reported Common Equity Tier 1 (CET1) ratio of 14.4% provides a substantial buffer for the forthcoming regulatory discussions.

Ad

UBS Stock: New Analysis - 17 March

Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated UBS analysis...

So schätzen die Börsenprofis UBS Aktien ein!

<b>So schätzen die Börsenprofis UBS Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | CH0244767585 | UBS | boerse | 68697884 |